VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ICLRICON Public Limited Company
$169.86$13.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksICLRCash Flow

ICON Public Limited Company (ICLR) Cash Flow Statement

28Y historyFree accessUpdated daily

Free cash flow remains highly volatile, swinging from a 29.5% margin in 2025Q4 to 6.7% in 2026Q1, reflecting inconsistent cash conversion efficiency across recent periods.

ICLR Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05May'05May'04May'03May'02May'01May'00May'99
Cash from Operations1.04B1.29B1.16B563.32M829.14M594.72M412.54M264.01M383.08M259.2M279.53M169.95M221.23M113.77M20.19M87.43M255.07M81.28M42.97M50.45M13.78M25.21M43.64M21.48M17.27M-1.57M8.4M1.5M
Operating CF Margin %12.56%15.54%14.3%7.28%15.13%21.26%14.7%10.17%21.79%15.55%17.75%11.3%16.56%10.2%2.14%9.71%28.74%9.39%6.81%11.07%3.98%7.72%14.7%9.52%11.03%-1.35%10.4%2.69%
Operating CF Growth %-19.46%10.82%106.11%-32.06%39.42%44.16%56.26%-31.08%47.79%-7.27%64.48%-23.18%94.45%463.47%-76.91%-65.72%213.81%89.18%-14.84%266.1%-45.33%-42.24%103.13%24.41%1199.94%-118.69%460.13%-
Net Income229.34M791.47M612.34M505.3M153.19M331.43M375.86M322.82M24.23M262.18M239.54M172.47M102.81M58.35M22.88M87.07M94.3M78.12M55.96M38.3M12.72M13.54M25.74M18.28M14.2M10.98M6.07M7.5M
Depreciation & Amortization383M528.29M585.95M569.51M314.99M95.07M61.55M65.92M191K59.58M57.68M52.54M46.51M42.82M38.68M33.87M32.66M27.73M18.89M14.84M13.88M13.13M10.6M7.27M5.97M4.96M3.23M2M
Stock-Based Compensation102.04M45.87M55.67M70.52M133.84M26.27M26.82M28.06M21.63M40.34M33.32M22.74M14.22M10.22M9.36M7.41M7.35M6.06M583K414K00000000
Deferred Taxes-128.92M0-85.4M-124.98M-60.62M50.75M-1.54M45.56M10.73M1.54M3.16M-7.9M-10.58M10.36M-6.12M2.33M-3.4M2.91M-1.18M-1.89M717K-532K985K376K19K-38K487K400K
Other Non-Cash Items548.85M-22.47M107.3M93.18M152.75M-23.51M32.6M-20.68M323.61M-1.12M67K35K313K-21.99M21K-84K115K321K5.75M4.07M-4.88M11.53M222K046K89K105K-200K
Working Capital Changes-98.1M-56.51M-114.82M-550.22M135M114.71M-82.74M-177.65M2.69M-103.31M-54.23M-69.94M67.95M14.02M-44.63M-43.17M124.04M-33.85M-37.04M-5.28M-8.64M-12.47M6.09M-4.44M-2.97M-17.56M-1.49M-8.2M
Change in Receivables-169.32M9.39M-78.58M-753.29M95.86M-175.04M-101.55M-37.56M57.75M2.53M-62.47M-7.03M-43.19M-64.8M-32.08M18.27M25.8M-83.82M-9.12M-27.8M5.96M-3.55M8.4M-23.23M-14.19M-21.62M-3.43M-3.02M
Change in Inventory00000-1.63M-69.7M-38K-45.19M-62.11M0-3.37M00-12.54M-32.63M60.05M20.43M0000000000
Change in Payables0000026.49M3.44M-5.07M2.53M1.18M3.12M-11.01M-2.06M1.04M-8.65M-28.54M37.83M29.55M2.34M1.34M-2.6M0000000
Cash from Investing-187.53M-266.79M-226.65M-145.87M-6.02B-46.58M-162.03M-37.3M-177.81M-74.81M-204.77M-112.32M-184.38M-121.11M-152.38M14.58M-65.69M-117.45M-118.47M-55.3M-16.28M-25.7M-47.34M-35.28M4.81M-22.57M7.66M-45.3M
Capital Expenditures-174.21M-168.06M-140.69M-142.16M-93.75M-51.05M-50.65M-48.4M-28K-42.6M-49.73M-32.78M-29.49M-30.79M-35.28M-30.95M-33.79M-67.88M-75.39M-31.52M-12.13M-15.6M-13.1M-52.66M-10.43M-6.69M-7.51M-9.4M
CapEx % of Revenue2.11%2.03%1.73%1.84%1.71%1.83%1.8%1.86%0%2.56%3.16%2.18%2.21%2.76%3.73%3.44%3.81%7.85%11.95%6.92%3.5%4.77%4.41%23.33%6.66%5.76%9.3%16.85%
Acquisitions-2.54M-84.16M-71.77M-1.91M-5.92B-40.21M-119.58M-1.65M89.8M-51.04M-166.1M-120.77M-92.51M-69.94M-61.54M-3.69M-25.9M-48.99M-41.15M-6.77M0-10.05M-11.26M00-1.9M00
Investments----------------------------
Other Investing0001.91M-10M000-258.97M0-458K00000501K400K00-3.37M-1.11M103K-1.17M-2.15M555K648K0
Cash from Financing-771.26M-837.18M-844.04M-864.17M5.11B-235.02M-125.41M-108.4M-119.28M-93.71M-81.39M-116.4M28.8M-1.58M-3.85M15.3M-105.06M22.34M93.96M7.7M6.62M938K42.52M-4.63M2.72M9.56M-1.43M2.2M
Debt Issued (Net)-29.76M-360.28M-895M-800M5.03B00000350M00000-109.88M9.9M89.83M112K4.83M4.83M-7.13M-7.13M-5.32M209K9.29M-1.2M
Equity Issued (Net)-740.28M-463.81M50.97M-64.14M117.74M-175M-146.93M-128.96M-133.11M-110M-457.89M-140.03M26.92M-15.61M-9.01M13.12M-84K-138K5.3M6.68M1.89M1.21M1.21M49.88M693K2.67M489K8K
Dividends Paid0000000000000000000000000000
Share Repurchases-750M-500M0-99.98M0-175M-146.93M-128.96M-133.11M-110M-457.89M-140.03M0-15.61M-9.01M0-84K-138K000-197K-197K00000
Other Financing-1.22M-13.09M-16K-34K-30.33M-60.02M21.52M20.56M13.83M16.29M26.51M23.63M1.88M14.03M5.16M2.18M4.91M12.58M-1.17M911K-96K-5.11M48.44M-47.38M7.34M6.68M-11.21M3.39M
Net Change in Cash108.51M160.68M89.33M-463.44M-88.09M320M124.46M112.99M90.32M88.63M-14.99M-63.62M68.47M-5.19M-136.47M110.91M86.42M-18.5M13.84M3.53M59.51M663K37.37M-17.98M25.11M-15.37M14.2M-42M
Free Cash Flow861.99M1.12B1.02B421.15M735.39M543.67M361.9M215.62M48.71M216.6M229.8M137.17M191.74M82.98M-15.09M56.48M221.28M13.4M-32.42M18.94M1.65M9.61M30.55M-31.18M6.84M-8.26M892K-7.9M
FCF Margin %10.45%13.51%12.57%5.44%13.42%19.44%12.9%8.31%2.77%13%14.59%9.12%14.35%7.44%-1.6%6.27%24.93%1.55%-5.14%4.16%0.48%2.94%10.29%-13.81%4.37%-7.11%1.1%-14.16%
FCF Growth %-22.94%9.63%142.27%-42.73%35.26%50.23%67.84%342.63%-77.51%-5.74%67.53%-28.46%131.07%649.79%-126.72%-74.48%1551.33%141.33%-271.23%1045.55%-82.81%-68.53%197.98%-555.52%182.87%-1025.9%111.29%-
FCF per Share10.9213.4712.345.1110.8010.206.663.940.893.843.812.173.081.37-0.250.933.690.22-1.090.660.060.702.23-2.560.56-0.690.04-0.66
FCF Conversion (FCF/Net Income)4.52x1.63x1.90x1.11x5.41x1.81x1.10x0.82x1.36x0.99x1.17x0.99x2.15x2.05x0.88x1.00x2.70x1.04x0.77x1.32x1.08x1.86x1.70x1.18x1.22x-0.14x1.38x0.19x
Interest Paid00317.98M210.92M106.2M13.06M13.06M13.06M13.09M13.62M2.17M533K548K602K388K0000000000000
Taxes Paid00163.78M116.32M55.1M27.6M29.84M18.56M12.3M10.21M14.83M17.83M14.1M18.48M22.72M0000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Backlog conversion and margin erosion

Earnings Quality and Cash Divergence

As reported in quarterly filings, ICON's operating cash flow to net income ratio has fluctuated wildly, reaching an extreme 5.15x in 2025Q4, which suggests that reported net income is currently a poor proxy for the company's actual ability to generate cash from its core operations.

The significant variance between net income and operating cash flow indicates that non-cash charges and working capital swings are heavily distorting the bottom line. Investors should monitor whether this divergence is a temporary accounting artifact or a sign that the company's underlying earnings quality is deteriorating as it struggles to convert clinical milestones into realized cash.

Free Cash Flow Margin Volatility

Based on the provided financial data, ICON's free cash flow margin has shown significant instability, swinging from a high of 29.5% in 2025Q4 to a low of 6.3% in 2025Q2, reflecting the inherent difficulty in maintaining consistent cash generation amidst a cooling clinical trial demand environment.

The erratic nature of these margins suggests that ICON's cash-generative capacity is highly sensitive to the timing of project milestones and client payments. This volatility complicates long-term valuation, as the company appears unable to sustain a predictable cash flow trajectory despite its scale in the CRO industry.

Working Capital Efficiency Under Pressure

According to recent SEC filings, ICON's working capital changes have been highly inconsistent, with a notable $169 million outflow in 2025Q2 followed by a $119 million inflow in 2025Q3, indicating that the company is facing significant friction in managing its cash conversion cycle effectively.

These sharp swings in working capital suggest that the company may be struggling with either delayed client collections or inefficient inventory management related to its site-based model. Such instability in the cash conversion cycle warrants further investigation into whether the company is being forced to extend payment terms to retain clients.

Aggressive Capital Allocation Amid Stagnation

As evidenced by the $500 million share repurchase in 2025Q4, ICON has prioritized returning capital to shareholders even as revenue growth has stalled, a strategy that may be premature given the company's low net margin of 2.78% and the ongoing integration challenges from recent acquisitions.

The decision to deploy significant cash toward buybacks while operating margins remain under pressure suggests a management focus on supporting the share price rather than reinvesting in operational efficiency. Investors should consider whether this capital allocation strategy limits the company's flexibility to address potential future liquidity needs or competitive threats.

ICLR — Frequently Asked Questions

Quick answers to the most common questions about buying ICLR stock.

How much cash does ICON Public Limited Company (ICLR) generate from operations?

ICON Public Limited Company (ICLR) generated $1.04B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is ICON Public Limited Company's free cash flow?

ICON Public Limited Company (ICLR) generated $862.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is ICON Public Limited Company's capital expenditure (CapEx)?

ICON Public Limited Company (ICLR) spent $174.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does ICON Public Limited Company distribute cash to shareholders?

In 2025, ICON Public Limited Company (ICLR) spent $750.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.